JP2011502147A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502147A5
JP2011502147A5 JP2010532037A JP2010532037A JP2011502147A5 JP 2011502147 A5 JP2011502147 A5 JP 2011502147A5 JP 2010532037 A JP2010532037 A JP 2010532037A JP 2010532037 A JP2010532037 A JP 2010532037A JP 2011502147 A5 JP2011502147 A5 JP 2011502147A5
Authority
JP
Japan
Prior art keywords
compound
formula
pharmaceutical composition
base
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010532037A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502147A (ja
JP5343082B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012224 external-priority patent/WO2009058267A2/en
Publication of JP2011502147A publication Critical patent/JP2011502147A/ja
Publication of JP2011502147A5 publication Critical patent/JP2011502147A5/ja
Application granted granted Critical
Publication of JP5343082B2 publication Critical patent/JP5343082B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010532037A 2007-10-29 2008-10-28 ベンゾモルホリン誘導体および使用方法 Expired - Fee Related JP5343082B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94807P 2007-10-29 2007-10-29
US61/000,948 2007-10-29
PCT/US2008/012224 WO2009058267A2 (en) 2007-10-29 2008-10-28 Benzomorpholine derivatives and methods of use

Publications (3)

Publication Number Publication Date
JP2011502147A JP2011502147A (ja) 2011-01-20
JP2011502147A5 true JP2011502147A5 (https=) 2011-09-22
JP5343082B2 JP5343082B2 (ja) 2013-11-13

Family

ID=40394086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010532037A Expired - Fee Related JP5343082B2 (ja) 2007-10-29 2008-10-28 ベンゾモルホリン誘導体および使用方法

Country Status (8)

Country Link
US (1) US7795254B2 (https=)
EP (1) EP2220078B1 (https=)
JP (1) JP5343082B2 (https=)
AU (1) AU2008319366B2 (https=)
CA (1) CA2703257C (https=)
ES (1) ES2417009T3 (https=)
MX (1) MX2010004620A (https=)
WO (1) WO2009058267A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH684182A5 (de) 1991-10-15 1994-07-29 Escher Wyss Ag Rotationsdruckmaschine.
AU2011254657B2 (en) * 2010-05-19 2016-02-04 Sandoz Ag Preparation of posaconazole intermediates
EP2571847B1 (en) 2010-05-19 2016-09-21 Sandoz AG Process for the preparation of chiral hydrazides
JP5955837B2 (ja) 2010-05-19 2016-07-20 サンド・アクチエンゲゼルシヤフト ポサコナゾール及びポサコナゾール中間体の精製
CA2838051C (en) 2011-06-16 2019-09-24 Sandoz Ag Process for the preparation of a chiral compound

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755332A (en) 1971-07-01 1973-08-28 Ciba Geigy Corp Substituted 4 indazolaminoquinolines
US4916135A (en) 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
AU4547396A (en) 1995-01-31 1996-08-21 Zenyaku Kogyo Kabushiki Kaisha Thioquinoline derivatives
GB9505702D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd Fungicidal compounds
GB9505651D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
US6143764A (en) 1995-11-07 2000-11-07 Kirin Beer Kabushiki Kaisha Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same
ATE201873T1 (de) 1995-11-14 2001-06-15 Pharmacia & Upjohn Spa Aryl- und heteroaryl- purin- und pyridopyrimidin- derivate
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
DE19614718A1 (de) 1996-04-15 1997-10-16 Hoechst Schering Agrevo Gmbh Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
WO1999054309A1 (en) 1998-04-23 1999-10-28 Takeda Chemical Industries, Ltd. Naphthalene derivatives, their production and use
US6313129B1 (en) 1998-08-21 2001-11-06 Hughes Institute Therapeutic compounds
SK288365B6 (sk) 1999-02-10 2016-07-01 Astrazeneca Ab Medziprodukty pre chinazolínové deriváty ako inhibítory angiogenézy
US6258820B1 (en) 1999-03-19 2001-07-10 Parker Hughes Institute Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
ES2231179T3 (es) 1999-04-12 2005-05-16 Aventis Pharma Limited Compuestos de heteroarilo biciclicos sustituidos como antagonistas de la integrina.
US6849625B2 (en) 2000-10-13 2005-02-01 Astrazeneca Ab Quinazoline derivatives with anti-tumour activity
DE60137273D1 (de) 2000-10-20 2009-02-12 Eisai R&D Man Co Ltd Verfahren zur Herstellung von 4-Phenoxy chinolin Derivaten
EP2258366B1 (en) 2001-06-22 2013-04-03 Kirin Pharma Kabushiki Kaisha Quinoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
GB0126433D0 (en) 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
JP2005515176A (ja) 2001-11-03 2005-05-26 アストラゼネカ アクチボラグ 抗腫瘍剤としてのキナゾリン誘導体
JP4608215B2 (ja) 2002-02-01 2011-01-12 アストラゼネカ アクチボラグ キナゾリン化合物
US7645878B2 (en) 2002-03-22 2010-01-12 Bayer Healthcare Llc Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
NZ535985A (en) 2002-03-29 2007-04-27 Chiron Corp Substituted benzazoles and use thereof as RAF kinase inhibitors
EP1548008A4 (en) 2002-08-23 2008-08-06 Kirin Pharma Kk COMPOUND WITH TGF-BETA-HEMMENDER EFFECT AND THIS MEDICAL COMPOSITION CONTAINING
EP1603884A4 (en) 2003-02-28 2008-05-28 Encysive Pharmaceuticals Inc PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE AND NAPHTHALENE UROTENSIN II RECEPTOR ANTAGONISTS
US7320989B2 (en) 2003-02-28 2008-01-22 Encysive Pharmaceuticals, Inc. Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
US7531553B2 (en) 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
GB0310401D0 (en) 2003-05-07 2003-06-11 Astrazeneca Ab Therapeutic agent
US7312330B2 (en) 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
JP4932495B2 (ja) * 2004-01-23 2012-05-16 アムゲン インコーポレイテッド 化合物及び使用方法
JO2787B1 (en) 2005-04-27 2014-03-15 امجين إنك, Alternative amide derivatives and methods of use

Similar Documents

Publication Publication Date Title
JP2013510120A5 (https=)
JP2006524222A5 (https=)
JP2016512822A5 (https=)
JP2008255122A5 (https=)
JP2012500260A5 (https=)
JP2009143956A5 (https=)
JP2014508811A5 (https=)
JP2012510502A5 (https=)
JP2011529054A5 (https=)
JP2006509749A5 (https=)
JP2009536660A5 (https=)
JP2005053931A5 (https=)
JP2010527983A5 (https=)
JP2008533007A5 (https=)
JP2011502147A5 (https=)
JP2008518890A5 (https=)
JP2015501820A5 (https=)
JP2015535839A5 (https=)
JP2015508092A5 (https=)
JP2012512863A5 (https=)
JP2014505017A5 (https=)
JP2012509265A5 (https=)
JP2018529657A5 (https=)
JP2010534246A5 (https=)
JP2019524752A5 (https=)